Leiden University Scholarly Publications

Your Search

Enabled Filters

  • (-) = Immunotherapy
  • (-) ≠ Pahl, J.H.W.
  • (-) ≠ Personalized medicine

Refine Results

Resource Type

Availability

Creation Date

Show more

Topic

Show more

Author

Show more

Language

Search results

  • RSS Feed
(49 - 72 of 132)

Pages

Prognostic significance of PD-1/PD-L1 expression in uveal melanoma: correlation with tumor-infiltrating lymphocytes and clinicopathological parameters
Remote control: the cancer cell-intrinsic mechanisms that dictate systemic inflammation and anti-tumor immunity
Immunotherapy for pancreatic cancer: chasing the light at the end of the tunnel
Immune monitoring in mesothelioma patients identifies novel immune-modulatory functions of gemcitabine associating with clinical response
Survival outcomes of patients with advanced melanoma from 2013 to 2017
Overcoming barriers to T cell activation, infiltration and function in tumors
Efficacy of nivolumab and ipilimumab in patients with malignant pleural mesothelioma is related to a subtype of effector memory cytotoxic T cells
Developing oncolytic viruses for clinical use: a consortium approach
Exploring and modulating the tumor immune microenvironment: Towards improving patient outcomes of immunotherapy in lung cancer
Personalizing treatment for malignant pleural mesothelioma
Vaccination and targeted therapy using liposomes : opportunities for treatment of atherosclerosis and cancer
A brief report on combination chemotherapy and anti-programmed death (ligand) 1 treatment in small-cell lung cancer
Survival outcomes of patients with advanced mucosal melanoma diagnosed from 2013 to 2017 in the Netherlands
Renal toxicity from pemetrexed and pembrolizumab in the era of combination therapy in patients with metastatic nonsquamous cell NSCLC
PARP and PD-1/PD-L1 checkpoint inhibition in recurrent or metastatic endometrial cancer
Design of TLR2-ligand-synthetic long peptide conjugates for therapeutic vaccination of chronic HBV patients
Photodynamic cancer therapy enhances accumulation of nanoparticles in tumor-associated myeloid cells
Synergizing systemic responses by combining immunotherapy with radiotherapy in metastatic non-small cell lung cancer: The potential of the abscopal effect
Humanized mouse models of genetic immune disorders and hematological malignancies
Therapeutic targeting of immune escaped cancers
Immunochemical approaches to monitor and modulate the adaptive immune system
Effects of checkpoint inhibitors in advanced non-small cell lung cancer at population level from the National Immunotherapy Registry
Co-delivery of immunomodulators in biodegradable nanoparticles improves therapeutic efficacy of cancer vaccines
Colorectal cancer: A paradigmatic model for cancer immunology and immunotherapy

Pages